Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOFLAME-19: Prednisolone and Losartan for Post-COVID Cardiac Involvement
NCT05619653Phase 3Active, not recruiting
- Start
- Dec 2022
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of prednisolone and losartan in post-acute sequelae of SARS-CoV-2 infection (PASC). Started Dec 2022; status: active, not recruiting.
02
Drugs
prednisolonelosartan
03
Conditions
post-acute sequelae of SARS-CoV-2 infection (PASC)
Beyond the preview
Go deeper on NCT05619653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05619653.